What is the best description of a tumor in an asymptomatic middle-aged or older adult male with a firm prostatic nodule on digital rectal examination (DRE), high-grade tumor cells on transrectal prostate biopsy, and iliac lymph node involvement on imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Higher-Gleason Score and Higher Stage (Answer A)

This patient has a high-grade prostate cancer (higher Gleason score) with lymph node metastases (higher stage), making Answer A the correct description.

Gleason Score Assessment

The histopathologic description reveals features diagnostic of high-grade prostate adenocarcinoma:

  • Sheets of tumor cells with no glandular differentiation indicate poorly differentiated cancer, which corresponds to Gleason pattern 5 1
  • Large vesicular nuclei and prominent nucleoli are characteristic features of high-grade prostate cancer 1
  • The absence of glandular architecture places this tumor in Grade Group 5 (Gleason score 9-10), representing the highest grade category 1

The International Society of Urological Pathology classification system defines Grade Group 5 as Gleason score 9-10, which includes tumors with predominantly pattern 5 (no glandular differentiation) 2, 3. This patient's biopsy clearly demonstrates these high-grade features.

Stage Assessment

The presence of enlarged iliac lymph nodes on imaging indicates regional nodal metastases:

  • Lymph node involvement classifies this as at least N1 disease (regional lymph node metastases) 1
  • According to the AUA/ASTRO guidelines, patients with high-risk prostate cancer should undergo pelvic imaging (mpMRI or CT) to evaluate for nodal disease 1
  • The European Association of Urology confirms that nodal metastases represent advanced stage disease 1
  • This patient meets criteria for high-risk prostate cancer based on Grade Group 4-5 alone, and the nodal involvement further confirms higher stage 1

Clinical Context and Staging Workup

For patients with high-grade tumors on biopsy:

  • Bone scan and pelvic imaging (CT or mpMRI) are strongly recommended to evaluate for metastatic disease 1
  • The NCCN guidelines recommend CT or mpMRI if clinical stage is T3-T4 or if the nomogram probability of lymph node involvement exceeds 10% 1
  • Patients with Grade Group 4-5 tumors have significantly elevated risk of nodal metastases, warranting comprehensive staging 1

Common Pitfalls to Avoid

  • Do not confuse Gleason grading with staging: Gleason score reflects tumor differentiation (grade), while TNM classification reflects anatomic extent (stage) 1
  • Nodal size criteria have limitations: CT and MRI assess nodal metastases based on size, which has imperfect sensitivity and specificity, but enlarged nodes in this clinical context are highly suspicious 1
  • The firm prostatic nodule on DRE suggests at least T2 disease (clinically palpable tumor), but the nodal involvement supersedes this in determining overall stage 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prostate Cancer Epidemiology and Clinical Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Algorithm for Prostate Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.